Social Media “Revolution” Expected In Adverse Events Signal Detection
This article was originally published in The Tan Sheet
Technology is ready now, and the agency anticipates Twitter and Facebook will become part of the “key instruments” of pharmacovigilance in the next five years, says Henry Francis, CDER’s data mining chief.
You may also be interested in...
The draft guidance outlines substantial reporting requirements for websites that firms control and for content on third-party sites – as well as saying when FDA intends to use enforcement discretion.
Five-point plan that calls for FDA to change definition of ‘labeling’ and ‘substantial evidence’ may offer hints as to what the next iteration of 21st Century Cures legislation will offer.
Breast cancer meeting highlights challenges of patient-focused drug development as breast cancer patients ask for trials to better identify characteristics of super-responders so patients can make more informed risk-benefit decisions.